Roger Warkentine

One of Benchmark International’s Major Transaction Teams, led by Managing Director Kendall Stafford, successfully facilitated the merger of Rx30 and Computer-Rx which closed on October 6, 2016. In June 2015, it was announced that GTCR had made a strategic equity investment in RX30, another deal facilitated by Benchmark International.

Computer-Rx, headquartered in Moore, Oklahoma, is an innovative pharmacy software platform focused on community pharmacies. Rx30, headquartered in Ocoee, Florida, is a leading national developer and supplier of vertical enterprise software that offers pharmacy management software solutions to the independent, hospital, long-term care and specialty pharmacy markets.

Each platform will continue to run independently while leveraging the combined experience and innovations of both companies. The Founder of Computer-Rx, Roger Warkentine, will remain on as an advisor and the current COO, Lauren Warkentine, will become President of Computer-Rx. Steve Wubker, CEO of Rx30, will lead the combined businesses.

Roger Warkentine commented, “The Benchmark team was invaluable throughout the deal. They recommended that we use the same attorneys they previously worked with for Rx30. With Benchmark and the attorneys’ combined knowledge of previous deals and industry standards, we knew that they would be the only representatives that would be able to agree to a great deal on our behalf while keeping our priorities in mind. The combination brings two companies with similar cultures and philosophies together to provide better resources for our clients.”

Benchmark's Chairman, Steven Keane, commented, “We are delighted with the outcome we were able to achieve for the Warkentine family. They were great to work with and were very deserving of the deal they received. It was a swift deal with obstacles the team had to overcome, but all parties were committed to a successful outcome. ”